Medical network on January 4 - review in 2016, in the growing need for public health, population aging process accelerate, comprehensive big background, the two children let go of our country medicine market is rapid development momentum. At the same time, the pharmaceutical industry development planning guide and a series of industrial policy releasing, to the high speed, orderly and healthy development of the pharmaceutical industry, pointed out the direction. Standing on the old node, looking ahead to 2017, which is worth focusing on medical field?
1. The biological medicine
In recent years, our country attaches great importance to biomedical technology innovation. "Made in China 2025" emphasize, vigorously promote biomedical and high-performance medical equipment in key areas such as the breakthrough development.
According to the 2025 "made in China, our country will develop in view of the major diseases of chemical medicine, traditional Chinese medicine (TCM), biotech drugs new products, mainly including the new mechanism and new targets for chemical medicine, antibody drugs, antibody coupling, a new structural protein and peptide drugs, new vaccines, traditional Chinese medicine (TCM) clinical advantage prominent innovation and personalized medicine.
In addition, China will also enhance the innovative ability of medical equipment and the level of industrialization, the development of imaging equipment, medical robot, such as high performance medical device, the degradation of stent high value medical consumables, wearable, remote diagnosis and treatment and other mobile medical products. Realize 3 d printing, induced pluripotent stem cells such as the breakthrough and the application of new technology.
Medicine for children 2.
Along with the comprehensive opening of child policy, children's medicine market will become more popular, children, such as the shortage of drugs, drug safety problem affects millions of parents' heart.
In December 2016, the national medicine for children who planning commission expert committee of fourth plenary conference. Meeting, in 2017, closely revolve around the center of children's healthy growth, set intellectual policy, joint coordination, continuous medication security work make recommendations for children, to promote drug supply security system reform new greater success.
In the pharmaceutical industry development planning guide "and other relevant policies, under the guide of children's drugs, such as the shortage of clinical drug development and production will be strengthened, children rich varieties and dosage forms with OTC drugs will gradually; Applicable to special populations such as children's high-end preparations will be focus on developing, and is in line with the international advanced quality standard gradually; More family five child safety packaging will come out, in order to strengthen the management of family medicine.
"The second child age" will also boost the big health product development. More pharmaceutical companies to functional foods, special medical use formula food, health care, prevention, not cure disease, and other fields.
3. The vaccine development
Vaccination is the most important means of prevention and control of infectious diseases, is "health umbrella". According to the pharmaceutical industry development planning guide, China will promote innovation upgrade, speed up the implementation of clinical need combination vaccine of localization.
In view of the highly pathogenic influenza, malaria, dengue fever, tuberculosis, AIDS, ebola, major infectious diseases such as respiratory syndrome village card, the Middle East, China will vigorously develop related vaccine development. At the same time, accelerate the thirteen pneumococcal conjugate vaccine, cervical cancer vaccine, such as respiratory syncytial virus vaccine clinical need for product development and industrialization.
The topic of the quality and safety of the vaccine is also widespread concern. To this, China will implement vaccine quality improvement plan. Is given priority to with vaccine immunization programmes key varieties, more development and multivalent vaccines, technology upgrading of existing vaccines and optimized production technology, improve the production process quality control key node, improve the circulation of cold chain traceability system, to improve the quality of vaccine safety.
4. Mobile medical
Under the impetus of the "Internet +", the medical market in the future will emerge more cloud services and the function of artificial intelligence mobile medical products, wearable devices, as well as various types of health management based on mobile Internet software (app), to realize remote monitoring, health consultation, online booking triage, case follow-up, inspection result query, health management service.
Our country attaches great importance to strengthen the development and utilization of health care big data. According to "about to promote and standardize health big data applications development guidance", by the end of 2017, the national and provincial population health information platform as well as the national drug bidding procurement business application platform, interconnection, basically in place across departments health data resources share a common pattern.
As more government departments, enterprises, scientific research units and medical institutions into electronic health records, electronic medical records, prescription of database construction, will help better through the connectivity and sharing of data resources, guide the diagnosis and treatment of disease, drug evaluation and new drug development, to constantly meet the multi-level and diverse public health demand, alleviate the problem of difficulty and high cost of treatment.
Traditional Chinese medicine 5.
In recent years, the "hot" of traditional Chinese medicine up constantly. Successively in 2016 published "China's traditional Chinese medicine", the white paper, the method of traditional Chinese medicine and other relevant policies and regulations reveals the development of China's efforts to promote the revitalization of traditional Chinese medicine of the confidence and determination. According to the pharmaceutical industry development planning guide, China will vigorously develop high quality Chinese medicine, to speed up the development of new technology and applications, promote products, technology, quality upgrading.
In the aspect of proprietary Chinese medicine. For cardiovascular disease, autoimmune diseases, especially disease, digestive department disease such as advantage of traditional Chinese medicine disease, classic square, encourage enterprises of traditional Chinese medicine mining development compound active ingredients, effective parts and traditional Chinese medicine new medicine, accelerate the curative effect and clinical value of high innovative drug research and development and industrialization of traditional Chinese medicines.
In the industrialization of technology. China will focus on developing the Chinese native medicine ingredient scale efficient separation and preparation technology, accord with the characteristics of traditional Chinese medicine slow release, the skin and mucous membrane to medicine, physical modification and new preparation technology such as mask taste, enhance the level of production process quality control and improve the testing technology and standards.
To accelerate the TCM upgrade product quality, quality improvement plan will be implemented in our country traditional Chinese medicine. Support Chinese medicine yinpian and traditional Chinese medicine (TCM) of essential medicines, traditional Chinese medicine injections, focus on product quality improvement; To develop and promote large varieties of traditional Chinese medicine production quality control standards and product standards, construction of the whole process of Chinese medicinal materials traceability system. |
